Scientists make breakthrough in fight against antibiotic resistance

July 29, 2016, University of Sheffield
MRSA
Methicillin-resistant Staphylococcus aureus. Credit: NIH/NIAID

Scientists have developed a pioneering new treatment to prevent bacterial skin infections, which could be used in the battle against 'superbugs', such as MRSA.

The new treatment, developed by researchers at the University of Sheffield in collaboration with AGE UK, is a new way to prevent , such as bed-sores and ulcers, becoming infected.

This new treatment has been proven to work on antibiotic-resistant bacteria, such as MRSA, which is currently one of the biggest threats to global healthcare and medicine.

Bacterial are a major problem for the elderly and people with , such as diabetes. Infected wounds heal more slowly, causing pain and distress for the patient, and are a significant cost to the NHS in the UK.

To launch an infection, bacteria attach tightly to skin cells and have learned to hijack 'sticky patches' on human cells to achieve this. Using proteins called tetraspanins, from , the Sheffield scientists have made these patches much less sticky, allowing bacteria to be harmlessly washed away.

The research has shown that these proteins prevent bacterial infections in a model of , which the scientists say give a clear indication that this treatment is both safe and effective.

This treatment was trialled on a model of 3D tissue engineered skin (TEskin) developed by engineers at the University.

The engineered skin, pioneered by Professor Sheila MacNeil from the University's Department of Materials Science and Engineering, can model infected wounds in human skin and mimics the tissue structure of normal adult skin. It can be used to analyse the penetration of peptides and bacteria.

Dr Pete Monk from the University's Department of Infection, Immunity and Cardiovascular Science, who led the study, said: "This development is a huge breakthrough in the fight against antibiotic-resistance.

"Skin infections, such as bed-sores and ulcers, can be incredibly troubling for patients who may already be dealing with debilitating conditions. They are also a significant problem for modern healthcare.

"We hope that this new therapy can be used to help relieve the burden of infections on both patients and health services while also providing a new insight into how we might defeat the threat of antimicrobial drug resistance.

"The therapy could be administered to patients using a gel or cream and could work well as a dressing. We're hoping it can reach clinical trials stage in the next three to five years."

Unlike conventional antibiotics, the tetraspanin proteins do not directly kill bacteria and so do not encourage the evolution of resistance.

Now, with substantial research funding from the Humane Research Trust, Sheffield scientists are developing the proteins for new anti-bacterial dressings that will help keep wounds sterile and so promote more rapid healing.

This development further cements the University's position at the forefront of world-class research into infectious diseases. Sheffield scientists are developing radical solutions to global problems of disease and antimicrobial resistance as part of projects including Florey and Imagine. These are signature research projects addressing some of the world's biggest biomedical problems.

Explore further: A small molecule outclasses larger ones in combating drug-resistant bacteria that cause skin infections

More information: Jennifer K. Ventress et al. Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes, PLOS ONE (2016). DOI: 10.1371/journal.pone.0160387

Related Stories

A small molecule outclasses larger ones in combating drug-resistant bacteria that cause skin infections

April 6, 2016
A promising drug candidate to address the growing problem of antibiotic-resistant skin infections has been discovered by A*STAR researchers.

Ultrasound accelerates skin healing—especially for diabetics and the elderly

July 13, 2015
Healing times for skin ulcers and bedsores can be reduced by a third with the use of low-intensity ultrasound, scientists from the University of Sheffield and University of Bristol have found.

Narrow wavelength of UV light safely kills drug-resistant bacteria

June 8, 2016
Scientists from the Center for Radiological Research at Columbia University Medical Center have shown that a narrow wavelength of ultraviolet (UV) light safely killed drug-resistant MRSA bacteria in mice, demonstrating a ...

Resistance to antibiotics and to immune system are interconnected in bacteria

June 30, 2016
Antibiotics and the immune system are the two forces that cope with bacterial infections. Now, two studies from Isabel Gordo's laboratory, at Instituto Gulbenkian de Ciência (IGC, Portugal), show for the first time that ...

Recommended for you

Reconstructing Zika's spread

May 24, 2018
The urgent threat from Zika virus, which dominated news headlines in the spring and summer of 2016, has passed for now. But research into how Zika and other mosquito-borne infections spread and cause epidemics is still very ...

Molecular network boosts drug resistance and virulence in hospital-acquired bacterium

May 24, 2018
In response to antibiotics, a gene regulation network found in the bacterium Acinetobacter baumannii acts to boost both virulence and antibiotic resistance. Edward Geisinger of Tufts University School of Medicine and colleagues ...

Past use of disinfectants and PPE for Ebola could inform future outbreaks

May 24, 2018
Data from the 2014 Ebola virus outbreak at two Sierra Leone facilities reveal daily usage rates for disinfectant and personal protective equipment, informing future outbreaks, according to a study published May 24, 2018 in ...

Tick bite protection: New CDC study adds to the promise of permethrin-treated clothing

May 24, 2018
The case for permethrin-treated clothing to prevent tick bites keeps getting stronger.

Early lactate measurements appear to improve results for septic patients

May 24, 2018
On October 1, 2015, the United States Centers for Medicare and Medicaid Services (CMS) issued a bundle of recommendations defining optimal treatment of patients suffering from sepsis, a life-threatening response to infection ...

Dengue: Investigating antibodies to identify at-risk individuals

May 23, 2018
Using an original mathematical and statistical analysis method, a team of scientists from the Institut Pasteur partnered with researchers from the United States and Thailand to analyze a Thai cohort that has long been a focus ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.